Abstract. Cell motility is involved in physiological and pathological processes such as the invasion and migration of cells. c-Jun N-terminal kinase (JNK) cascades are involved in the invasion and metastasis of cancer cells. However, little is known about the downstream signaling of JNK. In the present study, we used small interfering RNA (siRNA) directed against JNK1 to reduce its expression. We used microarray techniques to compare the gene expression profiles of epidermal growth factor (EGF)-stimulated HeLa cells with and without JNK1 siRNA treatment. We identified a JNK1 target gene, myosin phosphatase-Rho interacting protein (M-RIP). RNA interference-mediated inhibition of JNK1 strongly inhibited M-RIP mRNA expression induced by EGF, as well as the invasion of HeLa cells. In addition, M-RIP siRNA-treated cells showed significantly reduced invasive activity. Thus, a functional analysis of JNK1 and M-RIP with RNA interference reveals a critical role for this cascade in the invasive behavior of cancer cells.
Introduction
The migration and invasion of neoplastic cells is a complex process that involves microfilament and microtubule reorganization, membrane extension, adhesion and retraction (1, 2) . One fundamental component of tumor cell invasion is increased cell migration. Epidermal growth factor (EGF) receptor activation is crucial for stimulating cell migration through receptor phosphorylation and the subsequent activation of downstream signaling pathways, including phospholipase C and the MAP kinase cascade (3, 4) . However, additional signaling inputs through extracellular matrix-integrin interactions also play important roles in modulating EGF-stimulated cell motility responses (5) . Focal adhesion kinase (FAK), a nonreceptor protein tyrosine kinase (PTK) which localizes to focal contact sites, is involved with both EGF receptors and integrin-associated signaling complexes (6) . FAK has been linked to the generation of signals for cell survival, cell cycle progression, and cell motility (3, 6) . FAK promotes both integrin-stimulated and growth factor-stimulated cell motility. Several signaling pathways which control cell migration, including the FAK pathway, converge at the c-Jun N-terminal kinases (JNKs) (3, 7) . The JNK family plays fundamental roles in inflammation, differentiation and apoptosis. In addition, JNK pathways (especially JNK1) have recently been implicated in the regulation of cell migration via the phosphorylation of nuclear transcription factor c-Jun/AP-1, paxillin and microtubule-associated protein (MAP) (8) (9) (10) (11) (12) .
Our goal in the present study was to identify additional downstream target genes for JNK1 in promoting EGFstimulated cell motility. To determine the genes that play a role in the JNK1 pathway, we used DNA microarray techniques to analyze the changes in gene expression in JNK1 siRNA-treated cells and control cells during EGF stimulation. We found that EGF stimulation significantly increased myosin phosphatase-Rho interacting protein (M-RIP) mRNA levels. This increase was specifically inhibited by JNK1 siRNA treatment. Both JNK1 and M-RIP siRNA treatment inhibited cell invasion through a Matrigel membrane. Our results indicate that EGF promotes cell invasion in part through the upregulation of M-RIP mRNA by the JNK1 cascade.
Materials and methods
Cell culture. HeLa cells were obtained from Dainippon Sumitomo Pharma (Tokyo, Japan) and cultured according to the manufacturer's instructions. DMEM medium was supplemented with 10% FBS, penicillin (100 units/ml) and streptomycin (100 μg/ml). Quantitative PCR analysis. Quantitative PCR amplification and detection were performed by using SYBR Premix Ex Taq Mixes (Takara, Tokyo, Japan) and a Roche light cycler (Roche Diagnostics K.K., Tokyo, Japan) according to the manufacturers' instructions. The specific primer sequences were designed as follows: Actin-S, 5'-CCTCATGAAGATC CTCACCGA-3'; Actin-AS, 5'-TTGCCAATGGTGATGAC CTGG-3'; M-RIP-S, 5'-TTTATGGCGGTTGGCTGCTCC-3'; M-RIP-AS, 5'-CCTCATTTCTTCCTGCCAGAG-3'; eIF4E-S, 5'-GTTCCTGGCCCACTCTGTAA-3'; and eIF4E-AS, 5'-CC TGGATCCTTCACCAATGT-3'. Cycling parameters were 95˚C for 15 min, then 50 cycles of 95˚C for 15 sec and 60˚C for 1 min. As a control, the mRNA level of actin was determined in real-time PCR assays for each RNA sample and was used to correct for experimental variations. Melting curves were performed by using dissociation curves to ensure that only a single product was amplified. Quantifications were performed in duplicate, and the experiments were repeated independently 3 times. Expression levels were normalized to individual actin mRNA levels. 
Data analysis. Differences between the control group and the obese group were analyzed with the Student's t-test performed with SPSS version 10.0 software. A two-sided P-value <0.05 was considered statistically significant. All values were expressed as the mean ± SD.
Results
Suppression of FAK by siRNA inhibited migration and invasion. We investigated cell migration and invasion after cells were treated with siRNA to inhibit the expression of FAK. To validate the assay system, HeLa cells were monitored in the presence of FAK siRNAs and a control siRNA (Fig. 1) . FAK plays a central role in the motility and invasion of cancer cells, including HeLa cells. We first examined the knockdown efficiency of FAK by immunoblotting. Two types of FAKspecific siRNAs strongly inhibited protein expression levels compared with the control siRNA (Fig. 1A) . By using scratch and invasion assays, FAK siRNA-treated HeLa cells were found to have significantly inhibited invasion and migration activity (Fig. 1B and C) . The FAK siRNA did not affect cell viability (data not shown).
Suppression of JNK1 inhibited cell invasive activity.
JNKs play crucial roles in cell migration and several developmental processes (13, 14) . Stimulation of FAK with EGF activates the MEKK, MEK and JNK cascade and induces cell migration and invasion (3) . To investigate the nature of FAK/JNK signaling, we designed selective JNK1 knockdown siRNA to discover the downstream targets of JNK1. JNK1 siRNA strongly and specifically inhibited JNK1 protein levels ( Fig. 2A) . We examined the invasive activity of cells treated with JNK1 siRNA, and we compared it to the invasiveness of cells treated with FAK siRNA and cells treated with a JNK inhibitor, SP600125. JNK1 inhibition with siRNA significantly reduced the invasive activity (Fig. 2B) .
Gene expression profile of JNK1 knockdown in EGF-treated HeLa cells.
We used a microarray analysis to compare the gene expression profiles of HeLa cells with and without JNK1 siRNA treatment which were stimulated with EGF. We identified several genes specifically upregulated by EGF treatment and inhibited by JNK1 siRNA (Fig. 3A) .
Validation of M-RIP and eIF4E by quantitative RT-PCR.
Next, we determined the M-RIP mRNA levels during EGF stimulation by quantitative RT-PCR (qRT-PCR; Fig. 3 ). The M-RIP gene was upregulated by EGF treatment, and this upregulation was reduced to normal levels in JNK1 siRNAtreated HeLa cells (Fig. 3B) . We also examined the eIF4E mRNA level by qRT-PCR and found that it was not reduced by JNK1 siRNA treatment (Fig. 3C) .
Suppression of M-RIP inhibited HeLa cell invasive activity.
Finally, we examined the role of M-RIP in cancer cell invasion. HeLa cells were transfected with control siRNA, JNK1 siRNA and M-RIP siRNA, and invasive activity was examined by a chamber assay. M-RIP siRNA reduced the M-RIP mRNA levels by 70% in comparison to control siRNA (Fig. 4A) . M-RIP siRNA-treated cells displayed invasive activity which was significantly reduced in comparison with that of control siRNA-transfected cells (Fig. 4B) .
Discussion
Initial studies of JNKs examined their ability to induce the phosphorylation of several transcription factors, such as the oncogene c-Jun. However, recent evidence indicates that JNKs have conserved their evolutionary role in cell movement, cytoskeleton rearrangement and migration. The ability of tumor cells to migrate from the primary tumor to surrounding tissues is a prerequisite for metastasis. JNK promotes increased motility of multiple cell types including tumor cells (8) (9) (10) (11) (12) . In addition, the inhibition of JNK by siRNA, an inhibitor (SP60025) or gene deletion significantly impairs the rate of migration of several different cell types (10, (12) (13) (14) .
The signaling molecules involved in JNK pathways are also essential for cell migration. Upstream from JNK pathways, elements such as EGF receptors, FAK/Src, MEK kinase 1 and MKK4/7 are essential for cell migration and development (3) . Additionally, JNK substrates such as paxillin, spir and MAP2 are directly involved in cell motility. However, the transcriptional regulation of cell invasion through the phosphorylation of transcription factors such as Jun by JNK has not been clearly studied. To address the underlying molecular mechanisms involved in the JNK1 pathway implicated in cancer cell motility, we used a microarray analysis to compare the expression profiles of EGF-stimulated HeLa cells with and without JNK1 siRNA treatment.
The inhibition of the JNK1 function by siRNA resulted in a decreased level of M-RIP transcription induced by EGF, as well as inhibition of HeLa cell invasion through a reconstituted basement membrane (Figs. 3 and 4) . M-RIP was initially identified as a 116-kDa human protein that interacts with both myosin phosphatase and RhoA (15, 16) . p116M-RIP colocalizes with both stress fibers and lamellapodia, has actin-bundling properties in vitro, and causes actin filament disassembly when overexpressed (17, 18) . In neurons, M-RIP is essential for neurite outgrowth and may act as a scaffold to target the myosin phosphatase complex to the actin cyto- skeleton (15) . These data strongly suggest that M-RIP regulates cell motility through actin regulation. Our data suggest that M-RIP transcription is regulated by the JNK1 pathway. We therefore conclude that EGF can potentially affect M-RIP transcription through the JNK1 regulatory pathway. We propose that JNK1 activation in vivo may upregulate M-RIP transcription, facilitating an invasive phenotype.
